Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Binimetinib Pill
DRUG
2 trials
Sponsors
Abramson Cancer Center at Penn Medicine
, H. Lee Moffitt Cancer Center and Research Institute
Conditions
BRAF V600 Mutation
KRAS Mutation-Related Tumors
Melanoma Stage III
Melanoma Stage IV
Non-Small Cell Lung Cancer
Early Phase 1
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
Recruiting
NCT04741997
H. Lee Moffitt Cancer Center and Research Institute
BRAF V600 Mutation, Melanoma Stage III, Melanoma Stage IV
Start: 2021-05-24
End: 2027-04-01
Target: 50
Updated: 2026-09-16
Phase 2
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
Completed
NCT04735068
Abramson Cancer Center at Penn Medicine
KRAS Mutation-Related Tumors, Non-Small Cell Lung Cancer
Start: 2021-04-09
End: 2023-12-31
Updated: 2025-04-01
Related Papers
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced <i>KRAS</i>-Mutant Non-Small Cell Lung Cancer
The Oncologist
2023-04-26
18 citations